Peter Mueller

2011

In 2011, Peter Mueller earned a total compensation of $3.9M as EVP, Global R&D Chief Scientific Officer at Vertex Pharmaceuticals, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$525,146
Option Awards$2,255,943
Salary$581,534
Stock Awards$562,494
Other$12,495
Total$3,937,612

Mueller received $2.3M in option awards, accounting for 57% of the total pay in 2011.

Mueller also received $525.1K in non-equity incentive plan, $581.5K in salary, $562.5K in stock awards and $12.5K in other compensation.

Rankings

In 2011, Peter Mueller's compensation ranked 1,476th out of 10,747 executives tracked by ExecPay. In other words, Mueller earned more than 86.3% of executives.

ClassificationRankingPercentile
All
1,476
out of 10,747
86th
Division
Manufacturing
545
out of 3,960
86th
Major group
Chemicals And Allied Products
117
out of 1,033
89th
Industry group
Drugs
67
out of 781
91st
Industry
Pharmaceutical Preparations
56
out of 571
90th
Source: SEC filing on March 28, 2014.

Mueller's colleagues

We found four more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2011.

2011

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2011

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2011

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2011

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

In-depth

You may also like